Large Abdominal Hernia Repair With SurgiMend 3.0

Completed

Conditions studied: Hernia

In brief

The rate of hernia recurrence at one year following repair of a large abdominal hernia with a biologic mesh is high, ranging from 30% to 100%, with a reported historic average rate of 40%. The purpose of this study is to evaluate the rate of hernia recurrence at one year following repair with SurgiMend 3.0, an FDA-cleared novel biologic mesh, the hypothesis being that such rate will be less than 20% at one year, representing a 50% reduction over the historic rate of 40%.

Key facts

Study ID
NCT00892333
Run by
Integra LifeSciences Corporation
People needed
122
Starts
2009-04-01
Expected to finish
2014-07-01
Last updated by the study team
2016-05-17

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.